BioMarin Pharmaceutical Investor Relations Material
Latest events
Q4 2023
BioMarin Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from BioMarin Pharmaceutical Inc
Access all reports
BioMarin Pharmaceueutical Inc. is a biopharmaceutical company that develops and commercializes innovative therapies for people with serious and life-threatening rare diseases and medical conditions.
Key slides for BioMarin Pharmaceutical Inc
R&D Day 2023
BioMarin Pharmaceutical Inc
Q4 2023
BioMarin Pharmaceutical Inc
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States